Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLIAN oral solution in acute schizophrenia
2004-004461-15Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of amisulpride in schizophrenia, sponsored by Sanofi. Primary endpoints: Clinical Global Impression (CGI) scale and PANSS positive scale. Started Jul 2005; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2004-004461-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004461-15.